110年8月9日18：20的News Online節目將為大家一起研讀1則7月15日ICRT EZ News及中央廣播電臺7月20日播出的1則英語新聞來和大家分享，分別為：
- Former AIT Director Christensen Leaves Taiwan
Former American Institute in Taiwan Director Brent Christensen has left the
He boarded an United Airlines flight back to the United States this morning.
Responding to media questions about whether he plans to visit Taiwan again in
the future, he said he will.
American Institute in Taiwan Director Brent Christensen：美國在臺協會（AIT）酈英傑處長
responding （to respond）to：回應、回答
in the future：將來、未來
In a Facebook post, President Tsai Ing-wen wished him a good journey, saying
that Taiwan will always be with him.
Christensen's successor, Sandra Oudkirk, arrived in Taiwan earlier this week
and is currently (目前) undergoing quarantine.
a good journey：一路順風
- Taiwan's COVID vaccine has been approved for EUA
國產高瑞新冠肺炎疫苗已被核准緊急使用授權（Emergency Use Authorization）
The Central Epidemic Command Center announced on Monday that Taiwan’s Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for a COVID-19 vaccine produced by Taiwan-based Medigen Vaccine Biologics.
The decision was made by a panel of 21 experts who held a vote on whether to approve the vaccine on Sunday. Eighteen members voted to approve, one opposed, and one asked for more data.
The new vaccine will also be reviewed by the Advisory Committee on Immunization Practices before it can be added to the national vaccination program. Once it’s approved, a small number of doses could be administered starting August.
The Central Epidemic Command Center：中央流行疫情指揮中心
Taiwan’s Food and Drug Administration (FDA)：臺灣食品藥物管理署
Taiwan-based Medigen Vaccine Biologics （MC Corp.）：國產高端疫苗（臺灣…為主，高端）疫苗生物製劑（股份有限公司）（Biologics：生物製劑）
Emergency Use Authorization （EUA）：緊急使用授權
the Advisory Committee on Immunization Practices（(ACIP）：預防接種組（免疫實踐諮詢委員會）。Advisory Committee：咨詢委員會。Immunization：免疫；免疫接種法。Practices：實踐、作法。
the national vaccination program：國內整體施打計畫（國家疫苗接種計劃）
Taiwan’s FDA Director Wu Shou-mei said the AstraZeneca vaccine was chosen for comparison with the Medigen vaccine because it was the only vaccine available in Taiwan at the time of testing. The tests found that the geometric mean titer (GMT) level of neutralizing antibodies in participants who got the Medigen vaccine was 3.4 times higher than those who received the AstraZeneca vaccine. The other key result was the vaccine’s sero-response rate, which is the percentage of people who generate an immune response. That was 95.5 percent, which is higher than the required 50 percent.
Wu said the Medigen vaccine is suitable for adults aged 20 and older, and each person needs two doses at least 28 days apart. Medigen must also provide a safety report every month and a report on the vaccine’s effectiveness after being administered in Taiwan and other countries after one year.
Taiwan’s FDA Director Wu Shou-mei：（臺灣）衛生福利部（Ministry of Health and Welfare, MOHW）食品藥物管理署（Food and Drug Administration, FDA）署長吳秀梅
the AstraZeneca vaccine：牛津/阿斯利康COVID-19疫苗
the Medigen vaccine：國產高端疫苗
the geometric mean titer （GMT）：幾何平均抗體效價（titer：效價、滴度，滴度是稀釋度的倒數。病毒滴度即病毒懸液的濃度，又稱病毒的效價，噬菌斑形成單位數或感染中心數，就是指pfu的數值。）